New hope for lupus brain fog: experimental drug shows promise in trial
NCT ID NCT07281105
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called EG-501 for people with lupus who experience cognitive impairment, often called "brain fog." The trial involved 131 participants who received either the drug or a placebo over 14 weeks. The goal was to see if EG-501 could safely improve memory and thinking skills, as measured by a standard cognitive test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
UT Health Houston
Houston, Texas, 77030, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict chemo brain before it happens?
- Can a simple test predict Alzheimer's before symptoms worsen?
- Can a simple exercise program boost brain and balance in aging minds?
- A 3-Minute phone test could transform Pre-Surgery screening for seniors
- Could a hearing aid be a shield against dementia?
- Can a Three-Drug combo quiet lupus kidney flares?